001     285635
005     20260313131516.0
024 7 _ |a 10.1093/bioadv/vbaf317
|2 doi
024 7 _ |a pmid:41808772
|2 pmid
024 7 _ |a pmc:PMC12970591
|2 pmc
037 _ _ |a DZNE-2026-00274
041 _ _ |a English
082 _ _ |a 004
100 1 _ |a Nasr, Mohammed Kamal
|b 0
245 _ _ |a Removing array-specific batch effects in GWAS mega-analyses by applying a two-step imputation workflow.
260 _ _ |a Oxford
|c 2026
|b Oxford University Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1773404024_16831
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Combining genetic data from different genotyping arrays (mega-analysis) increases statistical power but introduces array-specific batch effects that may bias results. This project developed a two-step genotype imputation workflow addressing this bias in studies using multiple genotyping platforms.Genotype data of 10 647 individuals generated using five different arrays were included. The two-step method involved creating intermediate array-type specific panels, which were then imputed against the 1000 Genomes reference panel. Batch effects were assessed using genetic principal component analysis of the combined imputed dataset. Performance was evaluated by comparing imputation quality and allele frequency differences between the two-step and the conventional array-specific imputation. Additionally, concordance with a whole-genome-sequenced subgroup was examined. Genome-wide association analysis on goiter risk and thyroid gland volume was conducted to compare outcomes between both imputation approaches.The workflow eliminated array-driven batch effect from the first 20 PCs and showed high correlation with the conventional approach for allele frequencies (r 2 > 0.99). GWAS using the two-step imputation confirmed known associations on thyroid traits and revealed novel loci for thyroid volume (TG, PAX8, IGFBP5, NRG1), and goiter (XKR6), the latter not significant in the conventional imputation.The study provides a workflow for high-quality imputation results without batch effects, fostering genetic analysis involving multiple genotyping arrays.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
700 1 _ |a König, Eva
|0 0000-0002-2079-3525
|b 1
700 1 _ |a Fuchsberger, Christian
|0 0000-0002-5918-8947
|b 2
700 1 _ |a Ghasemi, Sahar
|b 3
700 1 _ |a Völker, Uwe
|0 0000-0002-5689-3448
|b 4
700 1 _ |a Völzke, Henry
|0 0000-0001-7003-399X
|b 5
700 1 _ |a Grabe, Hans J
|0 P:(DE-2719)2811781
|b 6
|u dzne
700 1 _ |a Teumer, Alexander
|0 0000-0002-8309-094X
|b 7
773 _ _ |a 10.1093/bioadv/vbaf317
|g Vol. 6, no. 1, p. vbaf317
|0 PERI:(DE-600)3076075-6
|n 1
|p vbaf317
|t Bioinformatics advances
|v 6
|y 2026
|x 2635-0041
856 4 _ |u https://pub.dzne.de/record/285635/files/DZNE-2026-00274.pdf
|y Restricted
856 4 _ |u https://pub.dzne.de/record/285635/files/DZNE-2026-00274.pdf?subformat=pdfa
|x pdfa
|y Restricted
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2811781
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2025-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2024-01-31T16:07:00Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2024-01-31T16:07:00Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2024-01-31T16:07:00Z
915 _ _ |a Creative Commons Attribution CC BY (No Version)
|0 LIC:(DE-HGF)CCBYNV
|2 V:(DE-HGF)
|b DOAJ
|d 2024-01-31T16:07:00Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-11-12
915 _ _ |a WoS
|0 StatID:(DE-HGF)0112
|2 StatID
|b Emerging Sources Citation Index
|d 2025-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-11-12
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2025-11-12
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2025-11-12
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of Dementia in the General Population
|x 0
980 _ _ |a journal
980 _ _ |a EDITORS
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-2719)5000001
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21